Dasser, O. et al. 2026. Generative AI for Drug Discovery: GPT-2 and LSTM-Based Models for Designing EGFR Inhibitors. Medinformatics. (Sep. 2026). DOI:https://doi.org/10.47852/bonviewMEDIN62029449.